These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 6698658)

  • 1. Steady-state kinetics of sustained-release phenylpropanolamine.
    Lönnerholm G; Grahnén A; Lindström B
    Int J Clin Pharmacol Ther Toxicol; 1984 Jan; 22(1):39-41. PubMed ID: 6698658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absorption and disposition kinetics of lithium carbonate following administration of conventional and controlled release formulations.
    Arancibia A; Corvalan F; Mella F; Concha L
    Int J Clin Pharmacol Ther Toxicol; 1986 May; 24(5):240-5. PubMed ID: 3089949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of multiple dosage bioavailability between phenylpropanolamine controlled release suspension and conventional tablet in healthy volunteers].
    Shen YX; Xu CD; Gao XH; Lin DC; Liu GL
    Yao Xue Xue Bao; 1995; 30(2):157-60. PubMed ID: 7785434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bioavailability of new nifedipine preparations in man. 1. Pharmacokinetics of nifedipine in the form of sustained-release tablets].
    Lutz D; Pabst G; Dahmen W; Molz KH; Jaeger H
    Arzneimittelforschung; 1985; 35(12):1840-2. PubMed ID: 4096741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of a sustained-release dosage form of clomipramine.
    Herrera D; Mayet L; Galindo MC; Jung H
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1488-93. PubMed ID: 11185671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bioavailability of etilefrine from Thomasin and Thomasin sustained-release tablets].
    Haustein KO; Hüller G
    Pharmazie; 1985 Nov; 40(11):776-8. PubMed ID: 2869507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of incadronate, a new bisphosphonate, in healthy volunteers and patients with malignancy-associated hypercalcemia.
    Usui T; Oiso Y; Tomita A; Ogata E; Uchida T; Ikeda K; Watanabe T; Higuchi S
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):239-44. PubMed ID: 9208339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of extended-release and immediate-release formulations of galantamine at steady state in healthy volunteers.
    Zhao Q; Janssens L; Verhaeghe T; Brashear HR; Truyen L
    Curr Med Res Opin; 2005 Oct; 21(10):1547-54. PubMed ID: 16238894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo evaluation of a sustained release preparation containing phenylpropanolamine hydrochloride.
    Yamakawa I; Shimomura M; Hattori T; Watanabe S; Tsutsumi J; Shinoda A; Miyake Y
    J Pharmacobiodyn; 1986 Dec; 9(12):947-52. PubMed ID: 3572716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of a sustained release formulation of pyridoxal phosphate of buflomedil after single or repeated oral doses in healthy volunteers.
    de Bernardi di Valserra M; Germogli R; Feletti F; Covini D; Borgonovo E
    Arzneimittelforschung; 1992 May; 42(5):632-6. PubMed ID: 1530676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of theophylline and bioavailability of a sustained release theophylline preparation in patients with cystic fibrosis.
    Valet SB; Schwartz RH; Brooks JG
    Ann Allergy; 1983 Mar; 50(3):161-5. PubMed ID: 6829982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suprofen sustained release kinetics in healthy male volunteers. 2nd communication: a multiple dose steady-state kinetics of suprofen sustained release tablets during 6 days in healthy male volunteers.
    Michos N; Zulliger HW; Möller T; Klein G
    Arzneimittelforschung; 1986 Jun; 36(6):949-54. PubMed ID: 3741529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The bioavailability and kinetics of dihydroquinidine in patients with heart disease.
    Regazzi Bonora M; Salerno JA; Rondanelli R; Cristiani D; Chimienti M
    Int J Clin Pharmacol Ther Toxicol; 1982 May; 20(5):212-8. PubMed ID: 7095920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and urinary excretion of eprosartan in Chinese healthy volunteers of different gender.
    Xu HR; Chen WL; Li XN; Liu GY; Chu NN; Yu C
    Pharmazie; 2007 Oct; 62(10):782-4. PubMed ID: 18236785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Indomethacin kinetics and urinary excretion of prostaglandin E2 following oral administration of various dosage forms of indomethacin].
    Düsing R; Dittrich P; Kukovetz WR; Lehmann K; Kramer HJ
    Z Rheumatol; 1983; 42(4):235-41. PubMed ID: 6580789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioavailability of amfepramone hydrochloride sustained release pellets formulation in healthy subjects.
    Dangor CM; Beckett AH; Veltman AM
    Arzneimittelforschung; 1987 Jun; 37(6):736-9. PubMed ID: 3663274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absolute bioavailability of amezinium. A cross-over study after i.v. and p.o. application.
    Kaumeier S; Kehrhahn OH; Morgenthaler H; Neugebauer G
    Arzneimittelforschung; 1981; 31(9a):1653-7. PubMed ID: 7197980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic properties of a new sustained-release theophylline preparation.
    Dahlqvist R; Billing B
    Int J Clin Pharmacol Ther Toxicol; 1983 Feb; 21(2):69-72. PubMed ID: 6840927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of etofylline after intravenous and oral administration to humans.
    Zuidema J; Verhoeven J; Merkus FW
    Int J Clin Pharmacol Ther Toxicol; 1981 Jul; 19(7):310-3. PubMed ID: 7263108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative deconvolution. An explicit method for bioavailability comparison not requiring intravenous administration.
    Veng-Pedersen P; Miller R
    Int J Clin Pharmacol Ther Toxicol; 1987 Jan; 25(1):10-4. PubMed ID: 3557723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.